Cited 0 times in
Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.